Home
About
Contact
NOTE: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.
Search Results
Tip
Select Recruitment Status
Active, not yet recruiting
Active, currently enrolling
Active, enrolling only by invitation
Enrollment complete
Study completed
Enrollment on hold
Study terminated early
Select Study Type
INTERVENTIONAL
OBSERVATIONAL
Select Clinical Trial Type
Phase I
Phase II
Phase IIA
Phase IIB
Phase III
Phase IV
n/a
Select Clinical Area
Adolescent Medicine
Addiction Medicine
Allergy and Immunology
Anesthesiology
Cardiology
Complimentary and Alternative Med
Dermatology
Emergency Medicine
Endocrinology, Diabetes and Metabolism
Epidemiology
Family Medicine
Genetics
Geriatric Medicine
Gastroenterology
Hematology
Infectious Diseases
Internal Medicine
Nephrology
Lifestyle Medicine
Neurology/Neurological Disorders
Nuclear Medicine
Nursing
Obstetrics and Gynecology
Occupational Medicine
Oncology (Adult)
Oncology (Pediatrics)
Ophthalmology
Other
Otolaryngology/ENT
Pediatrics
Physical Medicine and Rehabilitation
Podiatric Medicine
Preventative Medicine
Psychiatry
Pulmonary Disease
Radiology
Rheumatology
Sports Medicine
Surgery (Colon and Rectal)
Surgery (General)
Surgery (Hand)
Surgery (Neurological)
Surgery (Orthopedic)
Surgery (Plastic)
Surgery (Thoracic)
Surgery (Urology)
Surgery (Vascular)
Urology
Select Regions
California - Northern
California - Southern
Colorado
Georgia
Hawaii
Mid-Atlantic
Northwest
Washington
Select Facility 1
Select Facility 2
Select Facility 3
Male
Female
Child (Birth - 17 yrs)
Adult (18 - 65 yrs)
Senior (66 and above)
Saved Studies
You currently don’t have any saved studies. To save a study, select the bookmark icon on the result listing.
Your search for
Dermatology | All Regions
returned
12
studies.
Active, currently enrolling
Who can join
A Study Assessing Rocatinlimab in Combination with Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants with Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-SHUTTLE)
Keywords:
Dermatology;Internal Medicine;Atopic Dermatitis;
Study Type:
Clinical Trial |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Baricitinib in Children from 6 Years to Less than 18 Years of Age with Alopecia Areata
Keywords:
Dermatology; Alopecia Areata; Hypotrichosis; Pathological…
Study Type:
Clinical Trial |
Region:
California - Northern
Active, currently enrolling
Who can join
A Multicenter, Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata.
Keywords:
Dermatology; Pathology; CP543.5001; Alopecia; Alopecia…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
Keywords:
Hidradenitis Suppurativa; HS; INCB054707; Povorcitinib; Acne inversa;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase II Study of Biomarker Driven Early Discontinuation of Anti-PD-1 Therapy in Patients with Advanced Melanoma (PET-Stop)
Keywords:
Oncology (Adult);Allergy and Immunology;Dermatology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
Active, currently enrolling
Who can join
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
Keywords:
Dermatology;
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, not yet recruiting
Who can join
A Phase 3, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
Keywords:
Hidradenitis Suppurativa; Hidradenitis; Acne inversa; HS; Povorcitinib;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma
Keywords:
Oncology (Adult);Dermatology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
Enrollment complete
Who can join
(E1697) PHASE III RANDOMIZED STUDY OF FOUR WEEKS HIGH DOSE IFN-2b in Stage T2b No, T3a-b No, T4a-b No, and T1-4, N1a, 2a, 3 (microscopic) MELANOMA
Keywords:
Oncology (Adult);Allergy and Immunology;Dermatology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
Enrollment complete
Who can join
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon alfa-2b for Resected High-Risk Melanoma
Keywords:
Oncology (Adult);Dermatology;Allergy and Immunology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
1
2